Metamizol Zentiva (Metamizole Sodium Monohydrate)

Metamizole primarily inhibits cyclooxygenase enzymes, leading to reduced prostaglandin synthesis. Lower prostaglandin levels diminish nociceptor sensitization and reset the hypothalamic temperature set‑point, providing both pain relief and fever reduction. Additional central mechanisms may also contribute to its analgesic effect.

The appropriate dose of Metamizol Zentiva is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, and clinical response. Dosage regimens are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

Safety data for Metamizole in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metamizole belongs to the pyrazolone class, offering both analgesic and antipyretic activity. Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), it has a lower risk of gastrointestinal irritation but carries a distinct risk of blood dyscrasias such as agranulocytosis. Choice of therapy depends on the clinical scenario and safety considerations.

Metamizol Zentiva should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme heat to maintain stability and potency throughout its shelf life.

Metamizol Zentiva is formulated for oral administration. The tablets (or oral dosage form) are taken by mouth with water, following the dosage instructions provided by the prescriber. It should be swallowed whole and not crushed or chewed unless specifically directed.

The most serious adverse reactions to Metamizol include agranulocytosis, severe allergic responses such as anaphylaxis, and rare skin conditions like Stevens‑Johnson syndrome. Patients should be monitored for signs of infection, rash, or unexplained fatigue, and any concerning symptoms should prompt immediate medical evaluation.

Metamizol is contraindicated in individuals with known hypersensitivity to Metamizole or other pyrazolones. It should be avoided in patients with a history of severe blood dyscrasias, and used with caution in those with renal or hepatic impairment. Pregnant or lactating women should consult their physician before use.